Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Virus
100%
International Networks
100%
Virus Neutralization
100%
HIV Neutralization
100%
Peripheral Blood Mononuclear Cells
50%
Pseudovirus
50%
Monoclonal Antibody
33%
Protective Immunity
33%
Neutralizing Antibodies
33%
Phase I Study
33%
Virus Infectivity
33%
Infectivity Assay
33%
Immunization
16%
International Collaboration
16%
Vaccine Evaluation
16%
Soluble CD4
16%
Luciferase
16%
Antigen Test
16%
Viral Infection
16%
HEK293 Cells
16%
Reporter Gene Expression
16%
Positive Control
16%
β-Galactosidase (β-Gal)
16%
Green Fluorescent Protein Reporter
16%
Genetic Subtypes
16%
HIV Antibodies
16%
Molecular Clone
16%
Gp160
16%
Vaccine Response
16%
P24 Antigen
16%
Vaccine Effectiveness
16%
Genetically Engineered Cells
16%
Engineered Cell Lines
16%
Assay Sensitivity
16%
Genetic Phenotype
16%
Fluorescent Reporter
16%
Pseudotyped Virus
16%
Immunology and Microbiology
Human immunodeficiency virus
100%
Peripheral Blood Mononuclear Cell
100%
Neutralization
100%
Neutralizing Antibody
100%
Monoclonal Antibody
66%
Blood Plasma
66%
Virus Infectivity
66%
Cell Line
33%
Target Cell
33%
Human Immunodeficiency Virus 1
33%
CD4
33%
Reporter Gene
33%
Beta-Galactosidase
33%
Engineered Cell
33%
Antigen P24
33%